← Leaderboards
Benjamin M Yeh
University Of California, San Francisco
$6,888,949
Attributed
$9,986,897
Total exposure
5
Grants
4
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $1.4M · FY2007–22$2M$1.5M$1M$500K$0
'07
'08
'09
'10
'11
'12
'13
'14
'15
'16
'17
'18
'19
'20
'21
'22
Funding mix
By agency
NIH$9,986,897 · 5
By mechanism
R01$8,094,939 · 3
R42$1,478,091 · 1
R21$413,867 · 1
Top collaborators
- Brian Bales2 shared
- Peter John Bonitatibus2 shared
- Yanjun Fu2 shared
- Peter Edic1 shared
- Bruce F Johnson1 shared
- Andrew Soliz Torres1 shared
Most similar at University Of California, San Francisco
Same institution · by research overlap
- Valentina Pedoia$2,642,521
- Jeffrey Long$1,146,636
- Paul Joseph Krezanoski$2,079,111
- Brian Bales$771,911
- Julio Carballido-Gamio$2,678,369
Others in their field
Top investigators on “Monitor”
- Jeffrey P Krischer · University Of South Florida$631,818,376
- David Divins · Consortium For Ocean Leadership, Inc$609,772,544
- Margaret Juliana McElrath · Fred Hutchinson Cancer Center$476,087,269
- Bambra Strokes · Ppd Development Lp$461,655,950
- David Heimbrook · Leidos Biomedical Research, Inc.$367,240,481
- Lawrence Corey · Fred Hutchinson Cancer Center$302,301,802
Research focus
MonitorBaseIodineX-Ray Computed TomographyBlood VesselsToxic EffectViscosityRoentgen RaysModalityRattusDesignImageScanningAnatomyAttenuationContrast MediaAmericanSignal TransductionCharacteristicsBloodFamily SuidaeTissuesGrantAnimals
Grant awards (17)
Nanoparticle CT Contrast Agent for New Capabilities in Tumor Detection, Staging, and Therapy Planning and Response$710,090
R01 · FY2022 · CA · contact PI
Nanoparticle CT Contrast Agent for New Capabilities in Tumor Detection, Staging, and Therapy Planning and Response$719,475
R01 · FY2021 · CA · contact PI
Nanoparticle CT Contrast Agent for New Capabilities in Tumor Detection, Staging, and Therapy Planning and Response$824,346
R01 · FY2020 · CA · contact PI
Nanoparticle CT Contrast Agent for New Capabilities in Tumor Detection, Staging, and Therapy Planning and Response$878,060
R01 · FY2019 · CA · contact PI
Augmenting Dual Energy CT for Novel Contrast Agents$489,046
R42 · FY2019 · DK · contact PI
Augmenting Dual Energy CT for Novel Contrast Agents$489,046
R42 · FY2018 · DK · contact PI
Augmenting Dual Energy CT for Novel Contrast Agents$499,999
R42 · FY2017 · DK · contact PI
Nanoparticle CT Contrast Agents for Reduced Radiation Dose and New Imaging Applic$773,656
R01 · FY2016 · EB
Nanoparticle CT Contrast Agents for Reduced Radiation Dose and New Imaging Applic$827,410
R01 · FY2015 · EB
Nanoparticle CT Contrast Agents for Reduced Radiation Dose and New Imaging Applic$893,928
R01 · FY2014 · EB
Nanoparticle CT Contrast Agents for Reduced Radiation Dose and New Imaging Applic$865,154
R01 · FY2013 · EB
Complementary Injectable Tungsten Contrast for Dual Contrast Dual Energy CT$182,117
R21 · FY2013 · EB · contact PI
Complementary Injectable Tungsten Contrast for Dual Contrast Dual Energy CT$231,750
R21 · FY2012 · EB · contact PI
CT Monitoring of Angiogenesis$451,578
R01 · FY2010 · CA · contact PI
CT Monitoring of Angiogenesis$461,348
R01 · FY2009 · CA · contact PI
CT Monitoring of Angiogenesis$401,513
R01 · FY2008 · CA · contact PI
CT Monitoring of Angiogenesis$288,381
R01 · FY2007 · CA · contact PI